(Q44425661)

2 December 2017

title

Optimising vaccination strategies in equine influenza (English)

1 reference

2 December 2017

4

1 reference

2 December 2017

Park AW

1

1 reference

2 December 2017

Wood JL

2

1 reference

2 December 2017

Newton JR

3

1 reference

2 December 2017

Mumford JA

5

1 reference

2 December 2017

Grenfell BT

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

2 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

2 December 2017

volume

21

1 reference

2 December 2017

issue

21-22

1 reference

2 December 2017

page(s)

2862-2870

1 reference

Secondary bacterial infections following an outbreak of equine influenza

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Modelling the spread of a viral infection in equine populations managed in Thoroughbred racehorse training yards.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

A Contribution to the Mathematical Theory of Epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Chaos and biological complexity in measles dynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Modelling equine influenza 1: a stochastic model of within-yard epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Experimental quantification of vaccine-induced reduction in virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900156-7

7 January 2021

10.1016/S0264-410X(03)00156-7

Identifiers

DOI

1 reference

2 December 2017

1 reference